AIMMUNE THERAPEUTICS, INC.

Profile

Company Names

AIMMUNE THERAPEUTICS, INC.
ALLERGEN RESEARCH CORP

Addresses

8000 MARINA BOULEVARD, SUITE 300, BRISBANE, CA 94005-1884

2000 ALAMEDA DE LAS PULGAS, SUITE 161, SAN MATEO, CA 94403

Phone Numbers

(650) 614-5220
650 614 5220

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$334,700,016.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-11-28 
$98,000,002.00 
$98,000,002.00 
$0.00 
Equity 
2
2016-11-23 
$156,700,012.00 
$156,700,012.00 
$0.00 
Equity 
1
2015-01-20 
$80,000,002.00 
$80,000,002.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DANIEL 
C. 
ADELMAN 
EXECUTIVE OFFICER
AIMMUNE THERAPEUTICS, INC.
SUSAN 
E. 
BARROWCLIFFE 
EXECUTIVE OFFICER
AIMMUNE THERAPEUTICS, INC.
GREGORY 
 
BEHAR 
DIRECTOR
PRONUTRIA BIOSCIENCES, INC.   |  AXCELLA HEALTH INC.   |  AIMMUNE THERAPEUTICS, INC.   |  PRECISION IBD, INC.   |  PROMETHEUS BIOSCIENCES, INC.   |  SONOVA HOLDING AG
ERIC 
H. 
BJERKHOLT 
EXECUTIVE OFFICER
SUNESIS PHARMACEUTICALS INC   |  AIMMUNE THERAPEUTICS, INC.
VICTOR 
 
COLUNGA 
EXECUTIVE OFFICER
VIOPTIX INC   |  ALLERGEN RESEARCH CORP
JAYSON 
D.A. 
DALLAS 
EXECUTIVE OFFICER, DIRECTOR
AIMMUNE THERAPEUTICS, INC.
STEPHEN 
G. 
DILLY, JR. 
EXECUTIVE OFFICER, DIRECTOR
ALLERGEN RESEARCH CORP   |  AIMMUNE THERAPEUTICS, INC.
PATRICK 
 
ENRIGHT 
DIRECTOR
XANODYNE PHARMACEUTICALS INC   |  CARDIODX INC   |  LONGITUDE VENTURE PARTNERS II, L.P.   |  INFACARE PHARMACEUTICAL CORP   |  ESPERION THERAPEUTICS, INC.   |  ALLERGEN RESEARCH CORP   |  SUTROVAX, INC.   |  ORBUS THERAPEUTICS, INC.   |  LONGITUDE VENTURE PARTNERS III, L.P.   |  ROCK STARR LLC   |  ROCKPOINT LLC   |  APTINYX INC.   |  CURASEN THERAPEUTICS, INC.   |  STICHTING ADMINISTRATIEKANTOOR SYNCREON   |  VERA THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.   |  LONGITUDE VENTURE PARTNERS V, L.P.   |  LONGITUDE PRIME FUND II, L.P.   |  BIOAGE LABS, INC.   |  VERADERMICS, INC   |  LONGITUDE 103.8 EAST, L.P.   |  INFINANT HEALTH, INC.
PATRICK 
G. 
ENRIGHT 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  CORCEPT THERAPEUTICS INC   |  ESPERION THERAPEUTICS, INC.   |  CARDIODX INC   |  APTINYX INC.   |  AIMMUNE THERAPEUTICS, INC.   |  ENDEAVOR BIOMEDICINES, INC.
KATHRYN 
E. 
FALBERG 
DIRECTOR
ARCA BIOPHARMA, INC.   |  AIMMUNE THERAPEUTICS, INC.   |  NUVATION BIO INC.
BRETT 
K. 
HAUMANN 
DIRECTOR
AIMMUNE THERAPEUTICS, INC.
MARK 
T. 
IWICKI 
DIRECTOR
MERUS N.V.   |  AIMMUNE THERAPEUTICS, INC.
JEFFREY 
H. 
KNAPP 
EXECUTIVE OFFICER
AIMMUNE THERAPEUTICS, INC.
MARK 
D. 
MCDADE 
DIRECTOR
FIVE PRIME THERAPEUTICS INC   |  DERMIRA, INC.   |  AIMMUNE THERAPEUTICS, INC.
MARY 
M. 
ROZENMAN 
EXECUTIVE OFFICER
AIMMUNE THERAPEUTICS, INC.
STACEY 
D. 
SELTZER 
DIRECTOR
ALLERGEN RESEARCH CORP   |  AIMMUNE THERAPEUTICS, INC.
DOUGLAS 
T. 
SHEEHY 
EXECUTIVE OFFICER
AIMMUNE THERAPEUTICS, INC.
JAMES 
 
TANANBAUM 
DIRECTOR
VITAE PHARMACEUTICALS, INC   |  TARSA THERAPEUTICS, INC.   |  WAVETEC VISION SYSTEMS INC   |  ALLERGEN RESEARCH CORP   |  FULCRUM THERAPEUTICS, INC.   |  INTERLINE THERAPEUTICS, INC.   |  FL2021-001, INC.   |  EIKON THERAPEUTICS, INC.   |  FL2020-004, INC.   |  FORESITE CAPITAL FUND VI LP   |  FORESITE CAPITAL FUND VI (FEEDER), LP   |  ALUMIS INC.
BRYAN 
L. 
WALSER 
DIRECTOR
ALLERGEN RESEARCH CORP
JOONKYOO (ANTHONY) 
 
YUN 
DIRECTOR
ALLERGEN RESEARCH CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-11-29
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-11-28 
2018-03-16
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-11-23 
2015-03-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE